Skip to main content
SpringerLink
Log in

Clinical Cases in Oncofertility

  • Chapter
  • First Online:
Oncofertility

Part of the book series: Cancer Treatment and Research ((CTAR,volume 156))

Abstract

As an emerging interdisciplinary field, oncofertility bridges oncology and reproductive endocrinology and infertility with the goal of expanding reproductive options for women with cancer. In this chapter, we present a series of clinical scenarios encountered in medical practice to illustrate some of the complex issues that arise in this field and offer suggestions for patient care.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Humaidan P, et al. Reproductive outcome using a GnRH antagonist (cetrorelix) for luteolysis and follicular synchronization in poor responder IVF/ICSI patients treated with a flexible GnRH antagonist protocol. Reprod Biomed Online. 2005; 11(6):679–84.

    Article  PubMed  CAS  Google Scholar 

  2. Delvigne A, Rozenberg S. Review of clinical course and treatment of ovarian hyperstimulation syndrome (OHSS). Hum Reprod Update. 2003; 9(1):77–96.

    Article  PubMed  CAS  Google Scholar 

  3. Ovarian hyperstimulation syndrome. Fertil Steril. 2008; 90(5 Suppl):S188–93.

    Google Scholar 

  4. Delvigne A, Rozenberg S. Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Hum Reprod Update. 2002; 8(6):559–77.

    Article  PubMed  CAS  Google Scholar 

  5. Engmann L, et al. The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study. Fertil Steril. 2008; 89(1):84–91.

    Article  PubMed  CAS  Google Scholar 

  6. Humaidan P, Papanikolaou EG, Tarlatzis BC. GnRHa to trigger final oocyte maturation: a time to reconsider. Hum Reprod. 2009; 24(10):2389–94.

    Article  PubMed  CAS  Google Scholar 

  7. Itskovitz-Eldor J, Kol S, Mannaerts B. Use of a single bolus of GnRH agonist triptorelin to trigger ovulation after GnRH antagonist ganirelix treatment in women undergoing ovarian stimulation for assisted reproduction, with special reference to the prevention of ovarian hyperstimulation syndrome: preliminary report: short communication. Hum Reprod. 2000; 15(9):1965–8.

    Article  PubMed  CAS  Google Scholar 

  8. De Jong D, et al. Pregnancy and birth after GnRH agonist treatment for induction of final oocyte maturation in a woman undergoing ovarian stimulation for ICSI, using a GnRH antagonist (Orgalutran/Antagon) to prevent a premature LH surge: a case report. J Assist Reprod Genet. 2001; 18(1):30–3.

    Article  PubMed  Google Scholar 

  9. Kol S, Solt I. GnRH agonist for triggering final oocyte maturation in patients at risk of ovarian hyperstimulation syndrome: still a controversy? J Assist Reprod Genet. 2008; 25(2–3):63–6.

    Article  PubMed  CAS  Google Scholar 

  10. Chen C. Pregnancy after human oocyte cryopreservation. Lancet. 1986; 1(8486):884–6.

    Article  PubMed  CAS  Google Scholar 

  11. Grifo JA, Noyes N. Delivery rate using cryopreserved oocytes is comparable to conventional in vitro fertilization using fresh oocytes: potential fertility preservation for female cancer patients. Fertil Steril. 2009; 93(2):391–6.

    Article  PubMed  Google Scholar 

  12. Yang D, et al. Live birth after the transfer of human embryos developed from cryopreserved oocytes harvested before cancer treatment. Fertil Steril. 2007; 87(6):1469 e1–4.

    Article  PubMed  Google Scholar 

  13. Yoon TK, et al. Live births after vitrification of oocytes in a stimulated in vitro fertilization-embryo transfer program. Fertil Steril. 2003; 79(6):1323–6.

    Article  PubMed  Google Scholar 

  14. Fabbri R, et al. Human oocyte cryopreservation: new perspectives regarding oocyte survival. Hum Reprod. 2001; 16(3):411–6.

    Article  PubMed  CAS  Google Scholar 

  15. Borini A, et al. Clinical outcome of oocyte cryopreservation after slow cooling with a protocol utilizing a high sucrose concentration. Hum Reprod. 2006; 21(2):512–7.

    Article  PubMed  CAS  Google Scholar 

  16. Van der Elst J. Oocyte freezing: here to stay? Hum Reprod Update. 2003; 9(5):463–70.

    Article  PubMed  Google Scholar 

  17. Hsieh YY, et al. Ultrarapid cryopreservation of human embryos: experience with 1,582 embryos. Fertil Steril. 1999; 72(2):253–6.

    Article  PubMed  CAS  Google Scholar 

  18. Tao T, Zhang W, Del Valle A. Human oocyte cryopreservation. Curr Opin Obstet Gynecol. 2009; 21(3):247–52.

    Article  PubMed  Google Scholar 

  19. Check JH. Advances in oocyte cryopreservation – part II: rapid cooling using vitrification. Clin Exp Obstet Gynecol. 2009; 36(1):5–9.

    PubMed  CAS  Google Scholar 

  20. Fadini R, et al. Human oocyte cryopreservation: comparison between slow and ultrarapid methods. Reprod Biomed Online. 2009; 19(2):171–80.

    Article  PubMed  CAS  Google Scholar 

  21. Cutting R, Barlow S, Anderson R. Human oocyte cryopreservation: evidence for practice. Hum Fertil (Camb). 2009; 12(3):125–36.

    Article  CAS  Google Scholar 

  22. Jemal A, et al. Cancer statistics, 2009. CA Cancer J Clin. 2009; 59(4):225–49.

    Article  PubMed  Google Scholar 

  23. Bines J, Oleske DM, Cobleigh MA. Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol. 1996; 14(5):1718–29.

    PubMed  CAS  Google Scholar 

  24. Oktay K, et al. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol. 2005; 23(19):4347–53.

    Article  PubMed  CAS  Google Scholar 

  25. Allred CD, et al. Soy diets containing varying amounts of genistein stimulate growth of estrogen-dependent (MCF-7) tumors in a dose-dependent manner. Cancer Res. 2001; 61(13):5045–50.

    PubMed  CAS  Google Scholar 

  26. Prest SJ, May FE, Westley BR. The estrogen-regulated protein, TFF1, stimulates migration of human breast cancer cells. FASEB J. 2002; 16(6):592–4.

    PubMed  CAS  Google Scholar 

  27. Cole PA, Robinson CH. Mechanism and inhibition of cytochrome P-450 aromatase. J Med Chem. 1990; 33(11):2933–42.

    Article  PubMed  CAS  Google Scholar 

  28. Smith IE, Dowsett M. Aromatase inhibitors in breast cancer. N Engl J Med. 2003; 348(24):2431–42.

    Article  PubMed  CAS  Google Scholar 

  29. Oktay K, et al. Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. J Clin Endocrinol Metab. 2006; 91(10):3885–90.

    Article  PubMed  CAS  Google Scholar 

  30. Azim AA, Costantini-Ferrando M, Oktay K. Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study. J Clin Oncol. 2008; 26(16):2630–5.

    Article  PubMed  CAS  Google Scholar 

  31. Oktay K. Further evidence on the safety and success of ovarian stimulation with letrozole and tamoxifen in breast cancer patients undergoing in vitro fertilization to cryopreserve their embryos for fertility preservation. J Clin Oncol. 2005; 23(16):3858–9.

    Article  PubMed  Google Scholar 

  32. Lobo RA. Potential options for preservation of fertility in women. N Engl J Med. 2005; 353(1):64–73.

    Article  PubMed  CAS  Google Scholar 

  33. Oktay K, Cil AP, Bang H. Efficiency of oocyte cryopreservation: a meta-analysis. Fertil Steril. 2006; 86(1):70–80.

    Article  PubMed  Google Scholar 

  34. Ovarian tissue and oocyte cryopreservation. Fertil Steril. 2006; 86(5 Suppl 1):S142–7.

    Google Scholar 

  35. Kodama H, et al. Status of the coagulation and fibrinolytic systems in ovarian hyperstimulation syndrome. Fertil Steril. 1996; 66(3):417–24.

    PubMed  CAS  Google Scholar 

  36. Signorello LB, et al. Female survivors of childhood cancer: preterm birth and low birth weight among their children. J Natl Cancer Inst. 2006; 98(20):1453–61.

    Article  PubMed  Google Scholar 

  37. Aurousseau MH, et al. Risk of thromboembolism in relation to an in-vitro fertilization programme: three case reports. Hum Reprod. 1995; 10(1):94–7.

    Article  PubMed  CAS  Google Scholar 

  38. Yinon Y, et al. Safety of IVF under anticoagulant therapy in patients at risk for thrombo-embolic events. Reprod Biomed Online. 2006; 12(3):354–8.

    Article  PubMed  Google Scholar 

  39. Marhhom E, Cohen I. Fertility preservation options for women with malignancies. Obstet Gynecol Surv. 2007; 62(1):58–72.

    Article  PubMed  Google Scholar 

  40. Jeruss JS, Woodruff TK. Preservation of fertility in patients with cancer. N Engl J Med. 2009; 360(9):902–11.

    Article  PubMed  CAS  Google Scholar 

  41. Kim SS, et al. Ovarian tissue harvested from lymphoma patients to preserve fertility may be safe for autotransplantation. Hum Reprod. 2001; 16(10):2056–60.

    Article  PubMed  CAS  Google Scholar 

  42. Oktay K, et al. Endocrine function and oocyte retrieval after autologous transplantation of ovarian cortical strips to the forearm. JAMA. 2001; 286(12):1490–3.

    Article  PubMed  CAS  Google Scholar 

  43. Sonmezer M, Oktay K. Fertility preservation in female patients. Hum Reprod Update. 2004; 10(3):251–66.

    Article  PubMed  Google Scholar 

  44. Donnez J, et al. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet. 2004; 364(9443):1405–10.

    Article  PubMed  CAS  Google Scholar 

  45. Meirow D, et al. Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy. N Engl J Med. 2005; 353(3):318–21.

    Article  PubMed  CAS  Google Scholar 

  46. Baird DT, et al. Long-term ovarian function in sheep after ovariectomy and transplantation of autografts stored at –196 C. Endocrinology. 1999; 140(1):462–71.

    Article  PubMed  CAS  Google Scholar 

  47. Radford JA, et al. Orthotopic reimplantation of cryopreserved ovarian cortical strips after high-dose chemotherapy for Hodgkin’s lymphoma. Lancet. 2001; 357(9263):1172–5.

    Article  PubMed  CAS  Google Scholar 

  48. Oktay K, Sonmezer M. Ovarian tissue banking for cancer patients: fertility preservation, not just ovarian cryopreservation. Hum Reprod. 2004; 19(3):477–80.

    Article  PubMed  Google Scholar 

  49. Kim SS. Fertility preservation in female cancer patients: current developments and future directions. Fertil Steril. 2006; 85(1):1–11.

    Article  PubMed  CAS  Google Scholar 

  50. Forabosco A, et al. Morphometric study of the human neonatal ovary. Anat Rec. 1991; 231(2):201–8.

    Article  PubMed  CAS  Google Scholar 

  51. Johnson J, et al. Germline stem cells and follicular renewal in the postnatal mammalian ovary. Nature. 2004; 428(6979):145–50.

    Article  PubMed  CAS  Google Scholar 

  52. Faddy MJ, et al. Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum Reprod. 1992; 7(10):1342–6.

    PubMed  CAS  Google Scholar 

  53. Chemaitilly W, et al. Acute ovarian failure in the childhood cancer survivor study. J Clin Endocrinol Metab. 2006; 91(5):1723–8.

    Article  PubMed  CAS  Google Scholar 

  54. Sklar CA, et al. Premature menopause in survivors of childhood cancer: a report from the childhood cancer survivor study. J Natl Cancer Inst. 2006; 98(13):890–6.

    Article  PubMed  Google Scholar 

  55. Hensley ML, Reichman BS. Fertility and pregnancy after adjuvant chemotherapy for breast cancer. Crit Rev Oncol Hematol. 1998; 28(2):121–8.

    Article  PubMed  CAS  Google Scholar 

  56. Damewood MD, Grochow LB. Prospects for fertility after chemotherapy or radiation for neoplastic disease. Fertil Steril. 1986; 45(4):443–59.

    PubMed  CAS  Google Scholar 

  57. Couto-Silva AC, et al. Factors affecting gonadal function after bone marrow transplantation during childhood. Bone Marrow Transplant. 2001; 28(1):67–75.

    Article  PubMed  CAS  Google Scholar 

  58. Wallace WH, et al. Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int J Radiat Oncol Biol Phys. 2005; 62(3):738–44.

    Article  PubMed  Google Scholar 

  59. Howell S, Shalet S. Gonadal damage from chemotherapy and radiotherapy. Endocrinol Metab Clin North Am. 1998; 27(4):927–43.

    Article  PubMed  CAS  Google Scholar 

  60. Nicosia SV, Matus-Ridley M, Meadows AT. Gonadal effects of cancer therapy in girls. Cancer. 1985; 55(10):2364–72.

    Article  PubMed  CAS  Google Scholar 

  61. Wallace WH, et al. Developing strategies for long term follow up of survivors of childhood cancer. BMJ. 2001; 323(7307):271–4.

    Article  PubMed  CAS  Google Scholar 

  62. Lie Fong S, et al. Anti-mullerian hormone as a marker of ovarian function in women after chemotherapy and radiotherapy for haematological malignancies. Hum Reprod. 2008; 23(3):674–8.

    Article  PubMed  CAS  Google Scholar 

  63. Larsen EC, et al. Reduced ovarian function in long-term survivors of radiation- and chemotherapy-treated childhood cancer. J Clin Endocrinol Metab. 2003; 88(11):5307–14.

    Article  PubMed  CAS  Google Scholar 

  64. Bath LE, et al. Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Mullerian hormone, inhibin B and ovarian ultrasound. Hum Reprod. 2003; 18(11):2368–74.

    Article  PubMed  CAS  Google Scholar 

  65. Giuseppe L, et al. Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD). Hematology. 2007; 12(2):141–7.

    Article  PubMed  Google Scholar 

  66. van Beek RD, et al. Anti-Mullerian hormone is a sensitive serum marker for gonadal function in women treated for Hodgkin’s lymphoma during childhood. J Clin Endocrinol Metab. 2007; 92(10):3869–74.

    Article  PubMed  Google Scholar 

  67. Husseinzadeh N, et al. The preservation of ovarian function in young women undergoing pelvic radiation therapy. Gynecol Oncol. 1984; 18(3):373–9.

    Article  PubMed  CAS  Google Scholar 

  68. Terenziani M, et al. Oophoropexy: a relevant role in preservation of ovarian function after pelvic irradiation. Fertil Steril. 2009; 91(3):935 e15–6.

    Article  PubMed  Google Scholar 

  69. Jenninga E, et al. Female fertility preservation: practical and ethical considerations of an underused procedure. Cancer J. 2008; 14(5):333–9.

    Article  PubMed  Google Scholar 

  70. Williams RS, Littell RD, Mendenhall NP. Laparoscopic oophoropexy and ovarian function in the treatment of Hodgkin disease. Cancer. 1999; 86(10):2138–42.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This research was supported by the Oncofertility Consortium NIH 8UL1DE019587, 5RL1HD058296.

Author information

Authors and Affiliations

  1. Department of Reproductive Endocrinology and Infertility, University of Pennsylvania, Philadelphia, PA, USA

    Laxmi A. Kondapalli & Clarisa R. Gracia

  2. Department of Obstetrics and Gynecology, The Second Hospital of Shandong University, Jinan, Shandong Province, China

    Fanzhen Hong

Authors
  1. Laxmi A. Kondapalli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fanzhen Hong
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Clarisa R. Gracia
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Laxmi A. Kondapalli .

Editor information

Editors and Affiliations

  1. Northwestern University, Feinberg School of Medicine, Chicago, 60611-3015, Illinois, USA

    Teresa K. Woodruff

  2. Northwestern University, Feinberg School of Medicine, Chicago, 60611-3015, Illinois, USA

    Laurie Zoloth

  3. Northwestern University, Feinberg School of Medicine, Chicago, 60611-3015, Illinois, USA

    Lisa Campo-Engelstein

  4. Northwestern University, Feinberg School of Medicine, Chicago, 60611-3015, Illinois, USA

    Sarah Rodriguez

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Kondapalli, L.A., Hong, F., Gracia, C.R. (2010). Clinical Cases in Oncofertility. In: Woodruff, T., Zoloth, L., Campo-Engelstein, L., Rodriguez, S. (eds) Oncofertility. Cancer Treatment and Research, vol 156. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-6518-9_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-6518-9_5

  • Published:

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4419-6517-2

  • Online ISBN: 978-1-4419-6518-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation